Differential expression of somatostatin receptor subtype-related genes and proteins in non-functioning and functioning adrenal cortex adenomas

Molecular Medicine Reports

Volumn 4, Issue 5, 2011, Pages 963-969

  Pisarek, Hanna ^a   Krupiński, Roman ^b   Kubiak, Robert ^a   Borkowska, Edyta ^a   Pawlikowski, Marek ^a   Winczyk, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b N Copernicus Hospital   (Poland)

Author keywords

Adrenal cortex adenomas; Somatostatin receptor subtypes

Indexed keywords

MESSENGER RNA; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ANALYSIS;

ADRENOCORTICAL ADENOMA; ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960415078     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.519     Document Type: Article

References (30)

1. Koch CHA, Pacak K and Chrousos G: Genetic endocrine disease. The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab 87: 5367-5384, 2002. (Pubitemid 36034330)
2. Patalano A, Brancato V and Mantero F: Adrenocortical cancer treatment. Horm Res 71 (Suppl 1): 99-104, 2009.
3. Szabó PM, Wiener Z, Tömböl Z, et al: Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors. Virchows Arch 455: 133-142, 2009.
4. Aquilera G, Parker DS and Catt KJ: Characterisation of somatostatin receptors in the rat adrenal glomerulosa zone. Endocr 111: 1376-1383, 1982.
5. Maurer R and Reubi JC: Somatostatin receptors in the adrenal. Mol Cell Endocrinol 45: 81-90, 1986. (Pubitemid 16125097)
6. Pisarek H and Pawlikowski M: Immunohistochemical localization of the somatostatin receptor subtype 2A in the rat adrenal gland. Folia Histochem Cytobiol 40: 127-130, 2002.
7. Epelbaum J, Bertherat J, Prevost G, et al: Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J Clin Endocrinol Metab 80: 1837-1844, 1995.
8. Mundschenk J, Unger N, Schulz S, Holt V, Schulz S, Steinke R and Lehnert H: Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy. J Clin Endocrinol Metab 88: 5150-5157, 2003. (Pubitemid 37452710)
9. Unger N, Serdiuk I, Sheu SY, et al: Immunohistochemical determination of somatostatin receptor subtypes 1, 2A, 3, 4 and 5 in various adrenal tumors. Endocr Res 30: 931-934, 2004.
10. Ueberberg B, Tourne H, Redman A, Walz MK, Schmid KW, Mann K and Petersenn S: Differential expression of the human somatostatin receptor subtypes SST1 to SST5 in various adrenal tumors and normal adrenal gland. Horm Metab Res 37: 722-728, 2005. (Pubitemid 43028072)
11. Unger N, Serdiuk I, Sheu SY, et al: Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours. Clin Endocrinol 68: 850-857, 2008. (Pubitemid 351703940)
12. Schally AV: Oncological applications of somatostatin analogues. Cancer Res 48: 6977-6985, 1988.
13. Pawlikowski M, Kunert-Radek J and Stȩpień H: Somatostatin - an antiproliferative hormone. In: Progress in Neuropeptide Research. Dohler KD and Pawlikowski M (eds). Birkhauser Verlag, Basel, pp. 3-12, 1989.
14. Lamberts SW, Krenning EP and Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 12: 450-482, 1991.
15. Mełeń-Mucha G, Winczyk K and Pawlikowski M: Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Anticancer Res 18: 3615-3620, 1998.
16. De Herder WW and Lamberts SW: Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 14: 53-57, 2002. (Pubitemid 34072964)
17. Voltering EA: Development of targeted somatostatin-based antiangiogenic therapy: a review and future perspectives. Cancer Biother Radiopharm 18: 601-609, 2003.
18. Hu C, Yi C and Hao Z: The effect of somatostatin and SSTR 3 on proliferation and apoptosis of gastric cancer cells. Cancer Biol Ther 3: 726-730, 2004. (Pubitemid 41351075)
19. Fischer WE, Doran TA, Muscarella P II, Boros L, Ellison CH and Schirmer WJ: Expression of somatostatin receptor subtypes 1-5 genes in human pancreatic cancer. J Nat Cancer Inst 90: 322-324, 1998. (Pubitemid 28182389)
20. Reubi JC, Waser B, Liu Q, Laissue JA and Schonbrunn A: Subcellular distribution of somatostatin SST2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J Clin Endocrinol Metab 85: 3882-3891, 2000.
21. Pisarek H, Stȩpień T, Kubiak R, Borkowska E and Pawlikowski M: Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation. Thyroid Res 2: 1, 2009.
22. Pisarek H, Stepień T, Kubiak R and Pawlikowski M: Somatostatin receptors in human adrenal gland tumors - immunohistochemical study. Folia Histochem Cytobiol 46: 345-351, 2008.
23. Schulz S, Schulz ST, Schmitt J, et al: Immunocytochemical detection of somatostatin receptors SST1, SST2A and SST3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 4: 2047-2052, 1998.
24. Ferone D, Pivonello R, van Hagen M, et al: Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes. Am J Physiol Endocrinol Metab 283: E1056-E1066, 2002. (Pubitemid 35216966)
25. De Sa SV, Correa-Giannella LM, Machado MC, et al: Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas. Endocr Relat Cancer 13: 69-78, 2006.
26. Van der Hoek J, Waaijers M, van Koetsveld PM, et al: Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. Am J Physiol Endocrinol Metab 289: E278-E287, 2005. (Pubitemid 41076629)
27. Pawlikowski M: Somatostatin receptors in human tumors - in vitro studies. In: Somatostatin Analogs in Diagnostics and Therapy. Pawlikowski M (ed). Landes Bioscience, pp. 39-46, 2007.
28. Hofland LJ and Lamberts SWJ: The patholophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24: 28-47, 2003. (Pubitemid 36223278)
29. Pfeiffer M, Koch T, Schröder H, et al: Homo-and heterodimerization of somatostatin receptor subtypes. Inactivation of SST3 receptor function by heterodimerization with SST2A. J Biol Chem 276: 14027-14036, 2001.
30. Grant M, Alturaihi H, Jaquet P, Collier B and Kumar U: Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol Endocrinol 22: 2278-2292, 2008.